Mallar Chakravarty is interested in the anatomy of the brain and how it changes through development, aging, and in illness.

Pierre Étienne is a psychiatrist in the geriatric psychiatry program of the Douglas Institute. He is interested in the early development of medication and in Alzheimer's Disease.

John Breitner, MD, has devoted his career to investigating factors that modify an individual’s risk of developing Alzheimer's Disease.

Judes Poirier who had discovered a novel genetic risk factor that triggers the common form of Alzheimer’s disease, again made history in June.  

Serge Gauthier has contributed to the development of new diagnostic and therapeutic approaches to Alzheimer's Disease and other dementing disorders.  

Véronique Bohbot investigates the neural correlates underlying visual and auditory spatial memory in normal and brain-damaged individuals.

Work from Rémi Quirion's lab has helped to characterize the roles of cholinergic synapses in Alzheimer Disease, neuropeptide Y in depression and learning, and calcitonin gene-related peptide (CGRP) in pain and opioid tolerance.

Watch this video presentation by Judes Poirier, PhD, CQ, during the 2011 Mini-Psych School.

Question period following a lecture by Serge Gauthier, MD, on Alzheimer's disease in 2007 (in French).

Between May 19 and September 30 of each year, the Douglas Institute prepares in case of a high or extreme heat wave, by instating a level of « Seasonal » Watch.